FOLLI, FRANCO
FOLLI, FRANCO
Dipartimento di Scienze della Salute
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE− 2 study
2025 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Lipidome profile of Cystic Fibrosis Related Diabetes, Type 1 and Type 2 Diabetes Mellitus: potential links to inflammation and glucose and lipid metabolism
2025 A. Mingione, C. Loretelli, M. Dei Cas, F. Pivari, M. Barcella, I. Merelli, A. Zulueta, R. Paroni, L.C. Morlacchi, V. Vaira, F. Gillani, M. Piccoli, L. Anastasia, E. Albi, I. Righi, M. Nosotti, P. Fiorina, A. Caretti, L. Rosso, F. Folli, P. Signorelli
TMEM219 signaling promotes intestinal stem cell death and exacerbates colitis
2025 F. D'Addio, G. Amabile, E. Assi, A. Maestroni, A. Petrazzuolo, C. Loretelli, A. Abdelasalam, M. Ben Nasr, I. Pastore, M.E. Lunati, V. Usuelli, M. Zocchi, A.J. Seelam, D. Corradi, S. La Rosa, V. Marin, M. Zangarini, M. Nardini, S. Porzio, F. Canducci, C. Nardini, B. El Essawy, M. Nebuloni, J. Yang, M. Venturini, G. Maconi, F. Folli, S. Danese, G. Zuccotti, G.M. Sampietro, S. Ardizzone, P. Fiorina
Continuous interstitial glucose monitoring in diabetic and non-diabetic critically ill patients is simple and accurate: comparison with venous, arterial and capillary glucose measurements
2025 D. Chiumello, M. Passeri, S. Coppola, E. Chiodaroli, S. Carnier, M. Montante, T. Pozzi, I. Goggi, F. Bifari, U. Mortola, L. Centofanti, F. Folli
Analysis of morbid obese diabetic and non-diabetic patients: clinical and social characteristics, habits and workup to undergo bariatric surgery in Lombardy, Italy
2025 A.E. Pontiroli, S. Guarino, M. Tagliabue, L. La Sala, L. Centofanti, S. Olmi, G. Sarro, A. Giovanelli, C. Asteria, E. Galfrascoli, U. Mortola, L. Bucciarelli, M.A. Zappa, E. Tagliabue, F. Folli
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
2024 M. Ben Nasr, V. Usuelli, S. Dellepiane, A.J. Seelam, T.V. Fiorentino, F. D'Addio, E. Fiorina, C. Xu, Y. Xie, H.B. Balasubramanian, E. Castillo-Leon, L. Loreggian, A. Maestroni, E. Assi, C. Loretelli, A. Abdelsalam, B. El Essawy, S. Uccella, I. Pastore, M.E. Lunati, G. Sabiu, A. Petrazzuolo, G. Ducci, E. Sacco, L. Centofanti, M. Venturini, S. Mazzucchelli, D. Mattinzoli, M. Ikehata, G. Castellano, G. Visner, L. Kaifeng, K.M. Lee, Z. Wang, D. Corradi, S. La Rosa, S. Danese, J. Yang, J.F. Markmann, G.V. Zuccotti, R. Abdi, F. Folli, P. Fiorina
The triglyceride-glucose index, blood glucose levels, and metabolic syndrome are associated with all-cause mortality in obesity
2024 A.E. Pontiroli, L. Centofanti, A.S. Zakaria, S. Cerutti, M. Dei Cas, R. Paroni, L. La Sala, E. Tagliabue, S. Magnani, F. Folli
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study
2024 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population. CA.ME.LI.A study 7 year follow-up
2024 M. Bignotto, E. Bianco, L. Centofanti, A. Russo, M. Dei Cas, P. Zermiani, C. Morano, F. Samartin, E. Bertolini, F. Bifari, C. Berra, M. Zuin, R. Paroni, P.M. Battezzati, F. Folli
Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis
2024 A. Galli, S. Moretti, N. Dule, E.S. Di Cairano, M. Castagna, P. Marciani, C. Battaglia, F. Bertuzzi, I. Pastore, P. Fiorina, S. La Rosa, A. Davalli, F. Folli, C. Perego
The Relationship of Glucose Intolerance/Diabetes and Overweight/Obesity with Sphingolipidoma Alterations
2024 C. Morano, L. Centofanti, M.V. DEI CAS, S. Penati, E. Bianco, M. Bignotto, C. Berra, P. Zermiani, R. Paroni, P.M. Battezzati, F. Folli
Investigating the Impact of Epstein-Barr Virus on Sphingolipid Composition in Extracellular Vesicles of Multiple Sclerosis Patients
2024 L. Centofanti, A. Zollo, M. Dei Cas, V. Citro, D. Giannandrea, E. Soleymaninejadian, A. Mingione, A. Corona, A. Priori, M. Miozzo, F. Folli, R. Paroni, R. Chiaramonte, F. Martinelli Boneschi
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
2024 M.E. Lunati, V. Cimino, D. Bernasconi, A. Gandolfi, P.S. Morpurgo, C. Tinari, E. Lazzaroni, L. Baruffaldi, M. Muratori, L. Montefusco, I. Pastore, A. Rossi, I.G. Franzetti, F. Muratori, R. Manfrini, O.E. Disoteo, R. Terranova, P. Desenzani, A. Girelli, R. Ghelardi, F. D'Addio, M. Ben Nasr, C. Berra, F. Folli, L. Bucciarelli, P. Fiorina
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic Impairment
2024 N. Ferri, S. De Martin, J. Stuart, S. Traversa, A. Mattarei, S. Comai, F. Folli, M. Pappagallo, C. Guidetti, C.E. Inturrisi, P.L. Manfredi
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)
2024 C. Guidetti, S.D. Martin, G. Serra, M. Apicella, L. Pani, M. Pappagallo, A. Mattarei, F. Folli, P. Manfredi, M. Fava
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial
2024 M. Fava, S.M. Stahl, L. Pani, S.D. Martin, A.J. Cutler, V. Maletic, C.W. Gorodetzky, F.J. Vocci, F.L. Sapienza, T.R. Kosten, C. Kröger, P. Champasa, C. O'Gorman, C. Guidetti, A. Alimonti, S. Comai, A. Mattarei, F. Folli, D. Bushnell, S. Traversa, C.E. Inturrisi, P.L. Manfredi, M. Pappagallo
Multiple beneficial effects of 1-year nutritional-behavioral intervention on anthropometric and metabolic parameters in overweight and obese boys
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
Effetti benefici sui parametri antropometrici e metabolici nei ragazzi sovrappeso e obesi dopo 1 anno di intervento nutrizionale-comportamentale
2023 I.A. Matelloni, M. Tosi, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
Beneficial effects on anthropometric and metabolic parameters in overweight and obese boys after 1 year nutritional-behavioral intervention
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
Metformin acts in the gut and induces gut-liver crosstalk
2023 N. Tobar, G.Z. Rocha, A. Santos, D. Guadagnini, H.B. Assalin, J.A. Camargo, A.E.S.S. Gonçalves, F.R. Pallis, A.G. Oliveira, S.A. Rocco, R.M. Neto, I.L. de Sousa, M.R. Alborghetti, M.L. Sforça, P.B. Rodrigues, R.G. Ludwig, E.C. Vanzela, S.Q. Brunetto, P.A. Boer, J.A.R. Gontijo, B. Geloneze, C.R.O. Carvalho, P.O. Prada, F. Folli, R. Curi, M.A. Mori, M.A.R. Vinolo, C.D. Ramos, K.G. Franchini, C.F. Tormena, M.J.A. Saad